Researchers at Severance Hospital have successfully found a treatment method for lupus nephritis that controls the transcription factor of inflammatory T cells.

Although clinical studies of biological agents targeting autoimmune cells or substances are underway, no new therapeutic agents have shown superior efficacy in lupus nephritis, according to Severance. Steroid-based injections of anti-cancer agents and oral immunosuppressant are the existing treatment methods.

For full article please click here.